✦ LIBER ✦

371 In vivo-chemosensitivity adapted primary chemotherapy in patients with primary breast cancer. First results of the Gepartrio-Pilot trial

✍ Scribed by G. von Minckwitz; G. Raab; J.U. Blohmer; B. Gerber; A. Löhr; S.D. Costa; H. Eldtmann; J. Hilfrich; C. Jacksisch; M. Kaufmann

Book ID: 118620545
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 175 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90403-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized clinical trial evaluating t

A randomized clinical trial evaluating the duration of chemotherapy in patients with primary, node-positive breast cancer

✍ M. Schumacher; G.Bastert Bojar; K. Hübner; W. Sauerbrei; C. Schmoor; M. Olschews 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 154 KB

A randomised trial of goserelin versus c

A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer – GABG-IV B-93

✍ Manfred Kaufmann; Erika Graf; Walter Jonat; Wolfgang Eiermann; Sabine Vescia; Ma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Preliminary results of a pilot-trial wit

Preliminary results of a pilot-trial with trastuzumab + weekly epidoxorubicin/docetaxel in the neoadjuvant treatment of primary, operable breast cancer

✍ G.G. Steger; C. Wenzel; R. Bartsch; M. Rudas; M.F. Gnant; C.C. Zielinski; R. Jak 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 413 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b

Primary Granulocyte Colony-Stimulating F

Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia

✍ Aarts, M. J.; Peters, F. P.; Mandigers, C. M.; Dercksen, M. W.; Stouthard, J. M. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 189 KB

24 Zoledronic acid (ZOL) as add-on thera

24 Zoledronic acid (ZOL) as add-on therapy in patients with tumour residuals after neoadjuvant chemotherapy for primary breast cancer – first interim safety analysis of the NATAN study (GBG 36)

✍ G. von Minckwitz; M.D. Zahm; H. Eidtmann; H. Tesch; A. du Bois; K. Schwedler; J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB